发明名称 TARGETED NUCLEOTIDE EXCHANGE WITH IMPROVED MODIFIED OLIGONUCLEOTIDES
摘要 Disclosed is an oligonucleotide for targeted alteration of a duplex DNA sequence. The duplex DNA sequence containing a first DNA sequence and a second DNA sequence which is the complement of the first DNA sequence. The oligonucleotide comprises a domain that is capable of hybridising to the first DNA sequence and which comprises at least one mismatch with respect to the first DNA sequence and also comprises at least one section that contains at least two modified nucleotides having a higher binding affinity compared to naturally occurring A, C, T or G nucleotides, wherein - at least one modified nucleotide is a LNA that is positioned at a distance of at least one nucleotide from the at least one mismatch and wherein, optionally, the oligonucleotide contains at most about 50% LNA modified nucleotides; and - at least one modified nucleotide is a C7-propyne purine or a C5-propyne pyrimidine.
申请公布号 NZ582721(A) 申请公布日期 2011.11.25
申请号 NZ20080582721 申请日期 2008.06.19
申请人 KEYGENE N.V. 发明人 BUNDOCK, PAUL
分类号 C12N15/10 主分类号 C12N15/10
代理机构 代理人
主权项
地址